244 related articles for article (PubMed ID: 31531703)
1. [Treatment of rheumatic disease with renal insufficiency].
Weiner SM
Orthopade; 2019 Nov; 48(11):927-935. PubMed ID: 31531703
[TBL] [Abstract][Full Text] [Related]
2. [Dosage and toxicity of antirheumatic drugs in renal insufficiency].
Weiner SM; Bergner R
Z Rheumatol; 2015 May; 74(4):300-9. PubMed ID: 25962451
[TBL] [Abstract][Full Text] [Related]
3. COX-2 inhibitors and the kidney.
Appel GB
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S37-40. PubMed ID: 11695250
[TBL] [Abstract][Full Text] [Related]
4. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
Joshua FF; Oakley SP; Major GA
Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
[TBL] [Abstract][Full Text] [Related]
5. NSAIDs and the kidney revisited: are selective cyclooxygenase-2 inhibitors safe?
Eras J; Perazella MA
Am J Med Sci; 2001 Mar; 321(3):181-90. PubMed ID: 11269794
[TBL] [Abstract][Full Text] [Related]
6. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
7. [Management of antirheumatic drugs in kidney failure].
Manganelli R; Manganelli S; Iannaccone S; De Simone W
G Ital Nefrol; 2015; 32(6):. PubMed ID: 26845207
[TBL] [Abstract][Full Text] [Related]
8. [Nephrological management and drug dosing in patients with rheumatic diseases and renal insufficiency].
Weiner SM
Z Rheumatol; 2022 Dec; 81(10):811-828. PubMed ID: 36350405
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular safety of non-steroidal anti-inflammatory drugs in chronic inflammatory rheumatic diseases.
Zavodovsky BV; Sivordova LE
Ter Arkh; 2018 Aug; 90(8):101-106. PubMed ID: 30701944
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of cyclooxygyenase-2-selective inhibitors.
Brater DC
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S15-20; discussion S21-3. PubMed ID: 11992745
[TBL] [Abstract][Full Text] [Related]
11. [Nonsteroidal anti-inflammatory drugs: cardiovascular, cerebrovascular and renal effects].
Batlouni M
Arq Bras Cardiol; 2010 Apr; 94(4):556-63. PubMed ID: 20498929
[TBL] [Abstract][Full Text] [Related]
12. [Nonsteroidal antirheumatic agents--present status and perspectives].
Curković B
Reumatizam; 2000; 47(2):7-10. PubMed ID: 11552613
[TBL] [Abstract][Full Text] [Related]
13. Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease.
LeLorier J; Bombardier C; Burgess E; Moist L; Wright N; Cartier P; Huckell V; Hunt R; Nawar T; Tobe S
Can J Cardiol; 2002 Dec; 18(12):1301-8. PubMed ID: 12518182
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory agents and renal function.
Brater DC
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):33-42. PubMed ID: 12528072
[TBL] [Abstract][Full Text] [Related]
15. Renal effects of nonselective NSAIDs and coxibs.
Weir MR
Cleve Clin J Med; 2002; 69 Suppl 1():SI53-8. PubMed ID: 12086295
[TBL] [Abstract][Full Text] [Related]
16. [Meloxicam--the balance of efficacy and safety].
Morović-Vergles J
Reumatizam; 2008; 55(2):85-6. PubMed ID: 19024285
[TBL] [Abstract][Full Text] [Related]
17. Interaction and selection of therapeutic agents in the elderly: NSAIDs and the ageing kidney.
Stillman MT
Scand J Rheumatol Suppl; 1989; 82():33-8. PubMed ID: 2638520
[TBL] [Abstract][Full Text] [Related]
18. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
Giovanni G; Giovanni P
J Nephrol; 2002; 15(5):480-8. PubMed ID: 12455713
[TBL] [Abstract][Full Text] [Related]
19. Pharmaco-epidemiological considerations in patients with arthritis and vascular disease of the kidney.
Bulpitt CJ
Scand J Rheumatol Suppl; 1986; 62():4-13. PubMed ID: 3492036
[TBL] [Abstract][Full Text] [Related]
20. [Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents].
Chiolero A; Würzner G; Burnier M
Nephrologie; 2000; 21(8):425-30. PubMed ID: 11213386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
